1.27
Precedente Chiudi:
$1.26
Aprire:
$1.26
Volume 24 ore:
7,379
Relative Volume:
0.03
Capitalizzazione di mercato:
$67.02M
Reddito:
-
Utile/perdita netta:
$-56.85M
Rapporto P/E:
-0.8146
EPS:
-1.559
Flusso di cassa netto:
-
1 W Prestazione:
-8.03%
1M Prestazione:
+1.61%
6M Prestazione:
-54.35%
1 anno Prestazione:
-81.19%
Fractyl Health Inc Stock (GUTS) Company Profile
Nome
Fractyl Health Inc
Settore
Industria
Telefono
781-902-8800
Indirizzo
3 VAN DE GRAAFF DRIVE, BURLINGTON
Confronta GUTS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
GUTS
Fractyl Health Inc
|
1.27 | 67.02M | 0 | -56.85M | 0 | -1.559 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
497.04 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
610.90 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
620.30 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
256.09 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
251.64 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-02-28 | Iniziato | Evercore ISI | Outperform |
2024-02-27 | Iniziato | BofA Securities | Buy |
2024-02-27 | Iniziato | Morgan Stanley | Overweight |
Fractyl Health Inc Borsa (GUTS) Ultime notizie
Discover Fractyl Health And 2 More Promising Penny Stocks - Yahoo Finance
Fractyl Health (NASDAQ:GUTS) Earns Buy Rating from Analysts at Canaccord Genuity Group - Defense World
Fractyl Health initiated with a Buy at Canaccord - TipRanks
Raymond James Financial Inc. Makes New Investment in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Sei Investments Co. Acquires Shares of 27,778 Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Norges Bank Makes New Investment in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Critical Analysis: Glaukos (NYSE:GKOS) & Fractyl Health (NASDAQ:GUTS) - Defense World
NeuroMetrix (NASDAQ:NURO) vs. Fractyl Health (NASDAQ:GUTS) Head-To-Head Survey - Defense World
HighTower Advisors LLC Acquires 10,921 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health, Inc. (GUTS): Insider Were Buying In Q1 2025 - Insider Monkey
10 Micro-Cap Stocks Insiders Were Buying in Q1 2025 - Insider Monkey
Fractyl Health Reports Positive Early Data Showing Revita® - GlobeNewswire
Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation - The Manila Times
Revolutionary Device Cuts Post-GLP-1 Weight Regain by 60% in Breakthrough Study - Stock Titan
Fractyl Health, Inc. (NASDAQ:GUTS) Shares Acquired by Bank of New York Mellon Corp - Defense World
16,414 Shares in Fractyl Health, Inc. (NASDAQ:GUTS) Purchased by Intech Investment Management LLC - The AM Reporter
Fractyl Health director Barnes acquires $40,210 in common stock - Investing.com India
Fractyl Health director Ajay Royan purchases $22,979 in common stock By Investing.com - Investing.com Australia
Fractyl Health director Ajay Royan purchases $22,979 in common stock - Investing.com India
FRACTYL HEALTH Executives Increase Their Stakes - TradingView
Fractyl Health director Barnes acquires $40,210 in common stock By Investing.com - Investing.com UK
FRACTYL HEALTH Director Bradley William Acquires 16,129 Shares - TradingView
Fractyl Health sets June 11 for 2025 stockholder meeting - Investing.com
Fractyl Health sets June 11 for 2025 stockholder meeting By Investing.com - Investing.com South Africa
Rhumbline Advisers Boosts Stock Holdings in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Spotlight On Fractyl Health And Two Other Intriguing Penny Stocks - Yahoo Finance
Fractyl Health Reports 2024 Financial Results and Strategic Progress - MSN
Earnings call transcript: Fractyl Health’s Q4 2024 results miss expectations, stock drops - Investing.com India
FRACTYL HEALTH Earnings Results: $GUTS Reports Quarterly Earnings - Nasdaq
Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates - TradingView
Fractyl Health Highlights Urgent Demand for Weight Maintenance Solutions Post-GLP-1 Therapy in Upcoming REMAIN-1 Study Amid Strategic Focus on Metabolic Health - Nasdaq
Fractyl's Weight Maintenance Study Hits 189 Patients: Can It Solve the GLP-1 Rebound Problem? - StockTitan
Earnings Scheduled For March 3, 2025 - Benzinga
Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025 - The Manila Times
Fractyl Health to Report Fourth Quarter and Full Year 2024 - GlobeNewswire
Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide ... - The Bakersfield Californian
Can This Metabolic Disease Pioneer Deliver Strong Q4 Results? Fractyl Health Reports March 3 - StockTitan
Fractyl Health, Inc. (NASDAQ:GUTS) Sees Significant Drop in Short Interest - MarketBeat
Stratos Wealth Partners LTD. Sells 21,148 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
After Plunging -19.55% in 4 Weeks, Here's Why the Trend Might Reverse for Fractyl Health, Inc. (GUTS) - Yahoo Finance
Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments - PharmaVoice
Insider Selling: Fractyl Health, Inc. (NASDAQ:GUTS) CEO Sells 90,972 Shares of Stock - MarketBeat
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Fractyl Health (NASDAQ:GUTS) Price Target Cut to $10.00 by Analysts at Morgan Stanley - MarketBeat
Potential Price Increase for Fractyl Health Inc (GUTS) After Recent Insider Activity - Knox Daily
Fractyl Health Inc Azioni (GUTS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):